Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TripSitter Clinic Ltd C.KETA

Alternate Symbol(s):  TSTTF

Industrials Conglomerates
TripSitter Clinic Ltd. is a Canada-based company. The Company has no active business.


CSE:KETA - Post by User

TripSitter Clinic Ltd
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(26)
•••
Post by XeniaTechieon Dec 17, 2021 2:29pm
87 Views
Post# 34241612

Scooping up a taxloss deal with TripSitter Clinic

Scooping up a taxloss deal with TripSitter Clinic

Top of my taxloss Christmas list is a sweet deal with TripSitter Clinic, at a severe discount of $0.33 at time of post, this is a solid scoop going into 2022. Lots of traction for mainstream adoption in ketamine assisted therapies with major healthcare provider Blue Cross now covering ketamine related treatments. Only going to be more accepted and accessible in the coming year

https://www.benzinga.com/markets/cannabis/21/11/24171403/psychedelic-medicine-major-health-providers-including-blue-cross-now-cover-ketamine-treatments
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities